Hydroxychloroquine for Tamoxifen Resistance in Breast CancerHydroxychloroquine for Tamoxifen Resistance in Breast Cancer
The antimalarial drug hydroxychloroquine overcomes breast cancer resistance to tamoxifen, according to preclinical studies of estrogen receptor-positive (ER+) mammary tumors. Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Health | Hematology | Hydroxychloroquine | Study | Tamoxifen